These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 23690235)

  • 1. Prognostic value of survivin expression in breast cancer patients: a meta-analysis.
    Song J; Su H; Zhou YY; Guo LL
    Tumour Biol; 2013 Aug; 34(4):2053-62. PubMed ID: 23690235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic and clinicopathological significance of survivin expression in bladder cancer patients: a meta-analysis.
    Lv S; Turlova E; Zhao S; Kang H; Han M; Sun HS
    Tumour Biol; 2014 Feb; 35(2):1565-74. PubMed ID: 24101190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of survivin in breast cancer: meta-analysis.
    Li Y; Ma X; Wu X; Liu X; Liu L
    Breast J; 2014; 20(5):514-24. PubMed ID: 25041354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of matrix metalloproteinase 9 expression in breast cancer patients: a meta-analysis.
    Song J; Su H; Zhou YY; Guo LL
    Asian Pac J Cancer Prev; 2013; 14(3):1615-21. PubMed ID: 23679245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of survivin on prognosis and clinicopathology of glioma patients: a systematic meta-analysis.
    Lv S; Dai C; Liu Y; Shi R; Tang Z; Han M; Bian R; Sun B; Wang R
    Mol Neurobiol; 2015; 51(3):1462-7. PubMed ID: 25063470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Value of β-catenin Expression in Breast Cancer Patients: a Meta-analysis.
    Zhang DP; Li XW; Lang JH
    Asian Pac J Cancer Prev; 2015; 16(14):5625-33. PubMed ID: 26320427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of survivin in patients with gastric cancer: a systematic review with meta-analysis.
    Liu JL; Gao W; Kang QM; Zhang XJ; Yang SG
    PLoS One; 2013; 8(8):e71930. PubMed ID: 23936532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic role of survivin in renal cell carcinoma: A system review and meta-analysis.
    Xiong C; Liu H; Chen Z; Yu Y; Liang C
    Eur J Intern Med; 2016 Sep; 33():102-7. PubMed ID: 27350406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Meta-analysis: prognostic value of survivin in patients with hepatocellular carcinoma.
    Liu JL; Zhang XJ; Zhang Z; Zhang AH; Wang W; Dong JH
    PLoS One; 2013; 8(12):e83350. PubMed ID: 24386184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of survivin in patients with non-small cell lung carcinoma: a systematic review with meta-analysis.
    Zhang LQ; Wang J; Jiang F; Xu L; Liu FY; Yin R
    PLoS One; 2012; 7(3):e34100. PubMed ID: 22457815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered cytoplasmic-to-nuclear ratio of survivin is a prognostic indicator in breast cancer.
    Brennan DJ; Rexhepaj E; O'Brien SL; McSherry E; O'Connor DP; Fagan A; Culhane AC; Higgins DG; Jirstrom K; Millikan RC; Landberg G; Duffy MJ; Hewitt SM; Gallagher WM
    Clin Cancer Res; 2008 May; 14(9):2681-9. PubMed ID: 18451232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of survivin and patients survival in non-small cell lung cancer: a meta-analysis of the published studies.
    Huang LN; Wang DS; Chen YQ; Zhao CL; Gong BL; Jiang AB; Jia W; Hu FD
    Mol Biol Rep; 2013 Feb; 40(2):917-24. PubMed ID: 23065255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of cytoplasmic-to-nuclear ratio of survivin as an indicator of improved prognosis in breast cancer.
    Rexhepaj E; Jirstrom K; O'Connor DP; O'Brien SL; Landberg G; Duffy MJ; Brennan DJ; Gallagher WM
    BMC Cancer; 2010 Nov; 10():639. PubMed ID: 21092276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicalpathological and prognostic significance of survivin expression in renal cell carcinoma: a meta-analysis.
    Pu Z; Wang Q; Xie H; Wang G; Hao H
    Oncotarget; 2017 Mar; 8(12):19825-19833. PubMed ID: 28178644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological and prognostic significance of survivin expression in renal cancer patients: a meta-analysis.
    Ma C; Lu B; Sun E
    Postgrad Med J; 2017 Apr; 93(1098):186-192. PubMed ID: 27489375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic and Clinicopathological Value of Survivin in Diffuse Large B-cell Lymphoma: A Meta-Analysis.
    Zhang Y; Wang J; Sui X; Li Y; Lu K; Fang X; Jiang Y; Wang X
    Medicine (Baltimore); 2015 Sep; 94(36):e1432. PubMed ID: 26356696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological and prognostic value of hypoxia-inducible factor-1α in breast cancer: a meta-analysis including 5177 patients.
    Zhao Z; Mu H; Li Y; Liu Y; Zou J; Zhu Y
    Clin Transl Oncol; 2020 Oct; 22(10):1892-1906. PubMed ID: 32166713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of matrix metalloproteinase 2 on prognosis and clinicopathology of breast cancer patients: a systematic meta-analysis.
    Chen Y; Wang X; Chen G; Dong C; Zhang D
    PLoS One; 2015; 10(3):e0121404. PubMed ID: 25816052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic role of survivin in patients with glioma.
    Zhang S; Zhang C; Song Y; Zhang J; Xu J
    Medicine (Baltimore); 2018 Apr; 97(17):e0571. PubMed ID: 29703049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of MMP Family Members Functions as Prognostic Biomarker for Breast Cancer Patients: A Systematic Review and Meta-Analysis.
    Ren F; Tang R; Zhang X; Madushi WM; Luo D; Dang Y; Li Z; Wei K; Chen G
    PLoS One; 2015; 10(8):e0135544. PubMed ID: 26270045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.